Regulation - Research, Markets & Marketing

Filter

Popular Filters

News briefs: Lexicon's IBS drug; Sanofi Pasteur launch in Thailand; Tranzyme drops TZP-102

17-12-2012

US drug developer Lexicon Pharmaceuticals (Nasdaq: LXRX) saw its shares leap 9.1% to $2.04 in premarket…

DiabetesGastro-intestinalsLexicon PharmaceuticalsLX1033Markets & MarketingPharmaceuticalRegulationResearchSanofiSanofi PasteurTranzymeTZP-102Vaccines

Structural defects holding back growth of Russia's pharmaceutical industry

03-12-2012

Despite having grown significant since 2009 and set to be worth $10.7 million by 2014, there are some…

EuropeMarkets & MarketingPharmaceuticalRegulationResearch

Medicines Australia sets up new taskforce on transparency for payments to doctors

14-08-2012

Medicines Australia has invited the Australian Medical Association, the Royal Australian College of Physicians,…

Asia-PacificFinancialMarkets & MarketingPharmaceuticalRegulationResearch

Russia's pharma industry impresses as economy continues to grow; report

01-07-2012

The Russian pharmaceutical industry will continue to expand due to government initiatives and increased…

EuropeMarkets & MarketingPharmaceuticalRegulationResearch

Bayer and Algeta’s Alpharadin efficacy confirmed; Almirall to market Xarelto in Spain

13-02-2012

German drug major Bayer (BAY: DE) and Norwegian partner Algeta (OSE: ALGETA) announced that the survival…

AlgetaAlmirallAlpharadinBayerCardio-vascularEuropeMarkets & MarketingOncologyPharmaceuticalRegulationResearchXarelto

Clinical market in CIS to exceed $940 million euros in 2014

12-02-2012

Clinical trials in the Commonwealth of Independent States (CIS) countries have been developing in a positive…

EuropeMarkets & MarketingPharmaceuticalRegulationResearch

Drug approval and launch for Novartis in China, where Quintiles expands

18-01-2012

Swiss drug major Novartis (NOVN: VX) says it has received regulatory approval in China from the State…

Asia-PacificDiabetesGalvusLucentisMarkets & MarketingNovartisOphthalmicsPharmaceuticalQuintilesRegulationResearch

New studies on Rx drugs: clinical trials reporting; off-label marketing; and use of antipsychotics

05-12-2011

US federal rules and regulations related to transparency of prescription drug studies and prohibitions…

Markets & MarketingNeurologicalNorth AmericaPharmaceuticalRegulationResearch

Merck & Co debuts Nexplanon in USA; gets negative FDA response on Zoely and Saflutan

10-11-2011

Merck & Co (NYSE; MRK), the USA’s second largest drugmaker, says that its Nexplanon (etonogestrel…

DiabetesJanuviaMarkets & MarketingMerck & CoNexplanonOphthalmicsPharmaceuticalRegulationReproductiveResearchSaflutanZoely

API production in Russia: scarce but slowly developing

14-07-2011

Over the past few years a trend toward slow development has been observed on the part of producers of…

EuropeGenericsMarkets & MarketingPharmaceuticalRegulationResearch

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top